Go to the profile of Isoplexis

Isoplexis

 

About Isoplexis

IsoPlexis is a life sciences company committed to advancing precision medicine in the fight against cancer, autoimmune and infectious diseases. The IsoPlexis single cell detection platform isolates single immune cells and analyzes their full functional response to assess the effectiveness of therapeutics and to predict patient clinical response. The newly introduced Isolight® Next Generation Single Cell Analysis system is a versatile precision engineering platform designed to understand and characterize differences among single cells, mapping thousands of cells per sample, to reveal full functional profiles and polyfunctionality among cell subsets to determine patient response and product quality.

Therapeutic Areas

Infectious Metabolic Oncology

Technologies

Other

Company Type

Biotechnology – Diagnostics

State of Ownership

Private

Sponsorship Group

Networker

Topics

Topics contributed to:

Oncology

Editions participated in:

September 2017 November 2017